Aberdeen Group
NEO icon

Aberdeen Group’s NeoGenomics NEO Stock Holding History

Aberdeen Group’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.2M Sell
1,931,525
-95,368
-5% -$920K 0.04% 348
2026
Q1 		$15M Buy
2,026,893
+227,954
+13% +$2.4M 0.02% 496
2025
Q4 		$21.2M Buy
1,798,939
+1,006,676
+127% +$10.9M 0.03% 409
2025
Q3 		$6.12M Buy
792,263
+379,165
+92% +$2.66M 0.01% 679
2025
Q2 		$3.02M Hold
413,098
– – 0.01% 750
2025
Q1 		$3.92M Buy
+413,098
New +$5.16M 0.01% 704

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Aberdeen Group's NEO Position: Q2 2026 in Review

Aberdeen Group reduced its NeoGenomics (NEO) stake by 4.7% in Q2 2026, selling an estimated $920K and leaving 1,931,525 shares worth $28.2M. The position accounts for 0.04% of the portfolio, ranked #348.

Aberdeen Group first reported a position in NEO in Q1 2025 and has held it in 6 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Aberdeen Group held 1,931,525 shares of NeoGenomics worth $28.2M as of Q2 2026.
  • Aberdeen Group sold 95,368 NeoGenomics shares in Q2 2026, an estimated $920K.
  • NeoGenomics made up 0.04% of Aberdeen Group's portfolio in Q2 2026, its #348 holding.
  • Aberdeen Group first reported a position in NeoGenomics in Q1 2025 and has held it in 6 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.